Market revenue in 2024 | USD 6.5 million |
Market revenue in 2030 | USD 12.1 million |
Growth rate | 11.1% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Obsessive Compulsive Disorder (OCD) |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 81.54% in 2024. Horizon Databook has segmented the Saudi Arabia deep brain stimulation devices market based on pain management, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia deep brain stimulation devices market is anticipated to grow at significant rate during the forecast period owing to improving healthcare infrastructure and increasing incidence of PD & essential tremor in the country.
Moreover, increase in disposable income due to economic growth and urbanization is anticipated to create lucrative growth opportunities for the market. Thus, key players in the market are strategically expanding their presence in the region and focusing on commercialization of their products at a relatively affordable price.
For instance, during FY 2018, Abbott received approval for its Infinity DBS system in Saudi Arabia for treatment of essential tremor and PD. The government of Saudi Arabia is diverting funds toward creating a robust healthcare infrastructure by developing new hospitals.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account